this agent has relative fibrin specificity and may provide therapeutic advantages over the conventional thrombolytic agents , urokinase and streptokinase , particularly when the latter are administered in the currently recommended dose schedules for treatment of pulmonary embolism .
C0038418
streptokinase
C0034065
pulmonary embolism